Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.EntreMed drug shows benefit in arthritis
Results from treatment studies in a preclinical model of rheumatoid arthritis demonstrated that daily oral administration of 2ME2 reduced clinical severity of joint inflammation and inhibited articular joint
Results from treatment studies in a preclinical model of rheumatoid arthritis demonstrated that daily oral administration of 2ME2 reduced clinical severity of joint inflammation and inhibited articular joint
Results of a study examined glomerular filtration rate (GFR), a measure of renal function, in stable congestive heart failure (CHF) patients with mild renal impairment treated with furosemide
SLx-4090 is an enterocyte-specific microsomal triglyceride transfer protein (MTP) inhibitor. Dyslipidemia is a condition where abnormal levels of lipids are present in the bloodstream. In the study, subjects
On October 2, 2006, Gilead and Myogen reported that they had entered into a definitive merger agreement for Gilead to acquire all of the outstanding shares of common
Results from the trial earlier in the year showed that the drug lymphostat-B failed to produce good results and reduce lupus symptoms. The company decided to extend the
Overactive bladder is a syndrome characterized by urinary urgency. Lower urinary tract symptoms include urinary hesitancy and intermittency and weak urinary stream. Researchers evaluated the effectiveness of the
The primary endpoint for the study is the determination of objective disease response. Secondary endpoints include evaluation of safety and tolerability of PXD101, stable disease rates, duration of
Earlier in the year, Warner Chilcott sought treble damages, costs and a permanent injunction against Schering and its US affiliate, Berlex over the Yaz patent. Under the settlement,
The blood disorder, paroxysmal nocturnal hemoglobinuria (PNH), is a life-threatening form of hemolytic anemia characterized by destruction of red blood cells by the body's complement system, a component
The positive results come after Bristol reported the long term effectiveness of Orencia in adults with rheumatoid arthritis. The study is designed to assess the efficacy and safety